|
MREO Mereo Biopharma Group Plc 1719714 |
| Balance Sheet |
|
Current Assets
|
86,723,000 |
|
Assets
|
88,746,000 |
|
Current Liabilities
|
14,208,000 |
|
Liabilities
|
16,210,000 |
|
Equity
|
72,536,000 |
|
Shares Out
|
769,263,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-23,414,000 |
|
Investing Cash Flow
|
-699,000 |
| Market Analysis |
Market Cap
|
631,564,515 |
|
Price
|
2.86 |
|
BVPS
|
0.09 |
|
PB
|
30.01 |
|
EPS
|
-0.33 |
|
PS
|
0.57 |
|
FCF
|
-24,113,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MREO documents filed with the SEC.
MREO Filings
Clear
